Adrian Rawcliffe, Director at Wave Life Sciences Ltd. (WVE), sold 32,230 shares at $6.79 ($219K) on 2025-11-13, disclosed to the SEC on 2025-11-14.
Scheduled sale ($219k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 16,115 | $109K | 50.0% |
| 2 | $6.79 | 16,115 | $109K | 50.0% |
| Total | $6.79 avg | 32,230 | $219K | 100% |
| Filing → |
| ADAP | SELL | 2025-01-17 | $18K | — | Filing → |
| ADAP | SELL | 2025-01-15 | $35K | — | Filing → |
| ADAP | SELL | 2024-01-17 | $28K | — | Filing → |